New York Bill Would Codify Access to Out-of-Network Comp Pharmacies

Why It Matters

By guaranteeing timely medication access, the bill reduces recovery delays and potential litigation, while clarifying cost responsibilities for pharmacies and insurers.

Key Takeaways

• Bill permits out-of-network pharmacies for workers’ comp prescriptions
• Applies when delays, authorizations, or emergencies hinder care
• Pharmacies must follow fee schedule and formulary requirements
• If claim denied, pharmacy bears medication cost
• Board must report impact on access, litigation, and costs

Pulse Analysis

The New York workers’ compensation landscape is poised for a significant shift as Assembly Bill A.B. 10413 moves to embed out‑of‑network pharmacy access into law. Historically, claimants depended on contracted pharmacy networks, which could create bottlenecks when a required drug was unavailable or when insurers delayed authorization. By formalizing the board’s July 2025 interim rules, the legislation offers a safety net that ensures injured employees receive essential medication without waiting for bureaucratic approvals, a factor that can be critical for conditions requiring immediate treatment.

From a business perspective, the bill balances patient needs with cost controls. While pharmacies may dispense drugs outside the network, they remain bound by the state’s workers‑comp fee schedule and formulary mandates, preserving predictability for insurers and employers. Moreover, the provision that pharmacies assume financial responsibility if a claim is later denied shifts risk downstream, encouraging careful verification of claim eligibility at the point of sale. This risk‑reallocation could prompt pharmacies to invest in better claim‑validation systems, potentially raising operational costs but also fostering more accurate billing practices.

The requirement for a three‑year impact report adds a layer of accountability, allowing policymakers to assess how expanded pharmacy access influences overall system expenses, litigation rates, and patient outcomes. If the data show reduced recovery times and fewer disputes, other states may emulate New York’s approach, reshaping national workers‑comp pharmacy policies. Conversely, unexpected cost spikes could trigger refinements to the fee schedule or tighter eligibility criteria. Stakeholders—employers, insurers, pharmacy chains, and advocacy groups—should monitor the bill’s implementation closely to adapt strategies and maintain compliance.